Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 235 results.
User Information
Export Records
  1. 1.   Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology
  2. Afonin, Kirill A.; Dobrovolskaia,Marina; Church, George; Bathe, Mark
  3. ACS NANO. 2020, AUG 25; 14(8): 9221-9227.
  1. 2.   Regulation of senescence and the SASP by the transcription factor C/EBP beta
  2. Salotti,Jacqueline; Johnson,Peter
  3. Experimental gerontology. 2019, Dec; 128
  1. 3.   Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
  2. Ma, Lichun; Hernandez,Maria; Zhao,Yongmei; Mehta,Monika; Tran,Bao; Kelly,Michael; Rae,Zachary; Hernandez, Jonathan M; Davis, Jeremy L; Martin, Sean P; Kleiner, David E; Hewitt, Stephen M; Ylaya, Kris; Wood, Bradford J; Greten, Tim F; Wang, Xin Wei
  3. Cancer cell. 2019, Oct 14; 36(4): 418-430.
  1. 4.   Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
  2. Forero, Adriana; Ozarkar, Snehal; Li,Hongchuan; Lee, Chia Heng; Hemann, Emily A; Nadjsombati, Marija S; Hendricks, Matthew R; So, Lomon; Green, Richard; Roy, Chandra N; Sarkar, Saumendra N; von Moltke, Jakob; Anderson,Steve; Gale, Michael; Savan, Ram
  3. Immunity. 2019, SEP 17; 51(3): 451-+.
  1. 5.   Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells
  2. Marusiak, Anna A.; Prelowska, Monika K.; Mehlich, Dawid; Lazniewski, Michal; Kaminska, Klaudia; Gorczynski, Adam; Korwat, Aleksandra; Sokolowska, Olga; Kedzierska, Hanna; Golab, Jakub; Biernat, Wojciech; Plewczynski, Dariusz; Brognard,John; Nowis, Dominika
  3. Oncogene. 2019, Apr 11; 38(15): 2860-2875.
  1. 6.   RNA-DNA fibers and polygons with controlled immunorecognition activate RNAi, FRET and transcriptional regulation of NF-B in human cells
  2. Ke, Weina; Hong, Enping; Saito, Renata F.; Rangel, Maria Cristina; Wang, Jian; Viard,Mathias; Richardson, Melina; Khisamutdinov, Emil F.; Panigaj, Martin; Dokholyan, Nikolay; Chammas, Roger; Dobrovolskaia, Marina A.; Afonin, Kirill A.
  3. Nucleic acids research. 2019, FEB 20; 47(3): 1350-1361.
  1. 7.   Transcription Factor Myeloid Zinc-Finger 1 Suppresses Human Gastric Carcinogenesis by Interacting with Metallothionein 2A
  2. Lin, Shuye; Wang, Xiaoyue; Pan, Yuanming; Tian, Rongmeng; Lin, Bonan; Jiang, Guosheng; Chen,Keqiang; He, Yuqi; Zhang, Lulu; Zhai, Wanli; Jin, Peng; Yang, Lang; Li, Guoqiang; Wu, Yun; Hu, Jiang; Gong, Wanghua; Chang, Zhijie; Sheng, Jian-qiu; Lu, Youyong; Wang,Jiming; Huang, Jiaqiang
  3. CLINICAL CANCER RESEARCH. 2019, Feb 1; 25(3): 1050-1062.
  1. 8.   Structural host- microbiota interaction networks
  2. Guven-Maiorov, Emine; Tsai, Chung-Jung; Nussinov, Ruth
  3. PLOS COMPUTATIONAL BIOLOGY. 2017, OCT; 13(10):
  1. 9.   Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies
  2. Nayar, Utthara; Sadek, Jouliana; Reichel, Jonathan; Hernandez-Hopkins, Denise; Akar, Gunkut; Barelli, Peter J.; Sahai, Michelle A.; Zhou, Hufeng; Totonchy, Jennifer; Jayabalan, David; Niesvizky, Ruben; Guasparri, Ilaria; Hassane, Duane; Liu, Yifang; Sei, Shizuko; Shoemaker, Robert; Warren, J. David; Elemento, Olivier; Kaye, Kenneth M.; Cesarman, Ethel
  3. JOURNAL OF CLINICAL INVESTIGATION. 2017, Jun; 127(6): 2066-2080.
  1. 10.   IKK alpha controls ATG16L1 degradation to prevent ER stress during inflammation
  2. Diamanti, Michaela A.; Gupta, Jalaj; Bennecke, Moritz; De Oliveira, Tiago; Ramakrishnan, Mallika; Braczynski, Anne K.; Richter, Benjamin; Beli, Petra; Hu, Yinling; Saleh, Maya; Mittelbronn, Michel; Dikic, Ivan; Greten, Florian R.
  3. JOURNAL OF EXPERIMENTAL MEDICINE. 2017, 2017-02-01; 214(2): 423-437.
  1. 11.   The Yersinia pestis Effector YopM Inhibits Pyrin Inflammasome Activation
  2. Ratner, Dmitry; Orning, M. Pontus A.; Proulx, Megan K.; Wang, Donghai; Gavrilin, Mikhail A.; Wewers, Mark D.; Alnemri, Emad S.; Johnson, Peter; Lee, Bettina; Mecsas, Joan; Kayagaki, Nobuhiko; Goguen, Jon D.; Lien, Egil
  3. PLOS PATHOGENS. 2016, Dec 2; 12(12): e1006035.
  1. 12.   JS-K, a Glutathione S-Transferase-Activated Nitric Oxide Donor With Antineoplastic Activity in Malignant Gliomas
  2. Weyerbrock, A.; Osterberg, N.; Psarras, N.; Baumer, B.; Kogias, E.; Werres, A.; Bette, S.; Saavedra, J. E.; Keefer, L. K.; Papazoglou, A.
  3. Neurosurgery. 2012, Feb; 70(2): 497-510.
  1. 13.   Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells
  2. Hurwitz, A. A.; Watkins, S. K.
  3. Cancer Immunology Immunotherapy. 2012, Feb; 61(2): 289-293.
  1. 14.   CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells
  2. Ko, C. Y.; Chang, L. H.; Lee, Y. C.; Sterneck, E.; Cheng, C. P.; Chen, S. H.; Huang, A. M.; Tseng, J. T.; Wang, J. M.
  3. Neurobiology of Aging. 2012, Feb; 33(2):
  1. 15.   Genomic HIV RNA Induces Innate Immune Responses through RIG-I-Dependent Sensing of Secondary-Structured RNA
  2. Berg, R. K.; Melchjorsen, J.; Rintahaka, J.; Diget, E.; Soby, S.; Horan, K. A.; Gorelick, R. J.; Matikainen, S.; Larsen, C. S.; Ostergaard, L.; Paludan, S. R.; Mogensen, T. H.
  3. Plos One. 2012, Jan; 7(1):
  1. 16.   IKK alpha represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin
  2. Liu, B.; Willette-Brown, J.; Liu, S.; Chen, X.; Fischer, S. M.; Hu, Y.
  3. Cell Death and Differentiation. 2011, Dec; 18(12): 1854-1864.
  1. 17.   Hypoxia, stem cells and bone tumor
  2. Zeng, W.; Wan, R.; Zheng, Y. H.; Singh, S. R.; Wei, Y. Y.
  3. Cancer Letters. 2011, Dec; 313(2): 129-136.
  1. 18.   Supplementation with alpha-Tocopherol or beta-Carotene Reduces Serum Concentrations of Vascular Endothelial Growth Factor-D, but Not -A or -C, in Male Smokers
  2. Mondu, A. M.; Rager, H. C.; Kopp, W.; Virtamo, J.; Albanes, D.
  3. Journal of Nutrition. 2011, Nov; 141(11): 2030-2034.
  1. 19.   RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis
  2. Lipkowitz, S.; Weissman, A. M.
  3. Nature Reviews Cancer. 2011, Sep; 11(9): 629-643.
  1. 20.   Novel Chalcone Derivatives as Potent Nrf2 Activators in Mice and Human Lung Epithelial Cells
  2. Kumar, V.; Kumar, S.; Hassan, M.; Wu, H. L.; Thimmulappa, R. K.; Kumar, A.; Sharma, S. K.; Parmar, V. S.; Biswal, S.; Malhotra, S. V.
  3. Journal of Medicinal Chemistry. 2011, Jun; 54(12): 4147-4159.
  1. 21.   The Role of Response Elements Organization in Transcription Factor Selectivity: The IFN-beta Enhanceosome Example
  2. Pan, Y. P.; Nussinov, R.
  3. Plos Computational Biology. 2011, Jun; 7(6): 14.
  1. 22.   Nitric oxide and redox mechanisms in the immune response
  2. Wink, D. A.; Hines, H. B.; Cheng, R. Y. S.; Switzer, C. H.; Flores-Santana, W.; Vitek, M. P.; Ridnour, L. A.; Colton, C. A.
  3. Journal of Leukocyte Biology. 2011, Jun; 89(6): 873-891.
  1. 23.   Cryptocaryols A-H, alpha-Pyrone-Containing 1,3-Polyols from Cryptocarya sp Implicated in Stabilizing the Tumor Suppressor Pdcd4
  2. Grkovic, T.; Blees, J. S.; Colburn, N. H.; Schmid, T.; Thomas, C. L.; Henrich, C. J.; McMahon, J. B.; Gustafson, K. R.
  3. Journal of Natural Products. 2011, May; 74(5): 1015-1020.
  1. 24.   Gain-of-Function Pyrin Mutations Induce NLRP3 Protein-Independent Interleukin-1 beta Activation and Severe Autoinflammation in Mice
  2. Chae, J. J.; Cho, Y. H.; Lee, G. S.; Cheng, J.; Liu, P. P.; Feigenbaum, L.; Katz, S. I.; Kastner, D. L.
  3. Immunity. 2011, May; 34(5): 755-768.
  1. 25.   Dendritic Cells from Humans with Hypomorphic Mutations in IKBKG/NEMO Have Impaired Mitogen-Activated Protein Kinase Activity
  2. Ma, C. A.; Wang, H. Y.; Temmerman, S.; Zhao, Y. G.; Wu, L. M.; Hornung, R. L.; Wara, D.; Jain, A.
  3. Human Mutation. 2011, Mar; 32(3): 318-324.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel